{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:11:57Z","timestamp":1761675117577},"reference-count":42,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T00:00:00Z","timestamp":1094601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Cyclo\u2010oxygenase\u20102 expression has been reported to play an important role in the metaplasia\u2010dysplasia\u2010carcinoma sequence in Barrett's oesophagus. However, the existence of cyclo\u2010oxygenase\u20102 expressing cells in Barrett's epithelium is still uncertain.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To identify the cells that express cyclo\u2010oxygenase\u20102 protein and to investigate the relationship between cyclo\u2010oxygenase\u20102 expression and mucin\u2010phenotype of Barrett's epithelium.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Sections from 466 biopsy samples of Barrett's epithelium from 358 non\u2010medicated patients were immunohistochemically examined for the cyclo\u2010oxygenase\u20102 expression, mucin\u2010phenotype, cell proliferation and apoptosis.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Cyclo\u2010oxygenase\u20102 expression was detected in 71.0% of Barrett's epithelium biopsy samples. In Barrett's epithelium with the gastric predominant mucin\u2010phenotype, cyclo\u2010oxygenase\u20102 expression was mainly found in stromal and deep epithelial cells, whereas in intestinal predominant mucin\u2010phenotype, it was mostly in superficial epithelial cell. A significant elevation of proliferating cell nuclear antigen index and suppression of apoptotic index was observed in Barrett's epithelium with superficial epithelial cyclo\u2010oxygenase\u20102 expression. Neither such elevation of proliferating cell nuclear antigen index nor the suppression of apoptotic index could be found in chronic non\u2010steroidal anti\u2010inflammatory drugs users.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Barrett's epithelium with intestinal mucin and superficial epithelial cyclo\u2010oxygenase\u20102 expression possess a higher proliferation potential, but this risk may be thwarted by non\u2010steroidal anti\u2010inflammatory drugs administration.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02195.x","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T08:18:36Z","timestamp":1095754716000},"page":"793-802","source":"Crossref","is-referenced-by-count":16,"title":["Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo\u2010oxygenase\u20102 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non\u2010steroidal anti\u2010inflammatory drugs usage"],"prefix":"10.1111","volume":"20","author":[{"given":"Y.","family":"Amano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kushiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chinuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Miyaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A. K.","family":"Rumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,16]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90607-3"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460100089030"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90420-H"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2002.123420"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01619.x"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.6.753"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.124907"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001215)88:6<856::AID-IJC3>3.0.CO;2-D"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1999.00791.x"},{"key":"e_1_2_14_11_2","first-page":"325","article-title":"Review: Molecular pathology of cyclooxygenase\u20102 in cancer\u2010induced angiogenesis","volume":"31","author":"Fosslien E.","year":"2001","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1615\/JEnvironPatholToxicolOncol.v21.i2.20"},{"key":"e_1_2_14_13_2","first-page":"733","article-title":"Inhibition of cyclooxygenase\u20102 and activation of peroxisome proliferator\u2010activated receptor\u2010gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells","volume":"11","author":"Michael MS","year":"2003","journal-title":"Int J Mol Med"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03599.x"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00543.2001"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010700400960"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-090X(03)00072-2"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01627.x"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01432.x"},{"key":"e_1_2_14_20_2","first-page":"2929","article-title":"Increased expression of inducible nitric oxide synthetase and cyclooxygenase\u20102 in Barrett's esophagus and associated adenocarcinoma","volume":"58","author":"Wilson KT","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.172"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02408.x"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00362.x"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1980.32"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910470222"},{"key":"e_1_2_14_26_2","first-page":"641","article-title":"Heterogenicity of mucin gene expression in normal and neoplastic tissues","volume":"53","author":"Ho SB","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_14_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/44.10.8813081"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01680.x"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/153685904774129694"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33580"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.53.1.27"},{"key":"e_1_2_14_32_2","first-page":"198","article-title":"Cyclooxygenase\u20102 expression in human esophageal carcinoma","volume":"59","author":"Zimmermann KC","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70254-X"},{"key":"e_1_2_14_34_2","first-page":"427","article-title":"Immunohistological study of cell cycle\u2010related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus","volume":"10","author":"Fujii T","year":"2003","journal-title":"Oncol Rep"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34244"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.124908"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32371"},{"issue":"2","key":"e_1_2_14_38_2","first-page":"S30","article-title":"Does chemoprevention of Barrett's esophagus using acid suppression and\/or COX\u20102 inhibition prevent neoplastic progression","volume":"2","author":"Fennerty MB.","year":"2002","journal-title":"Rev Gastroenterol Disord"},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I"},{"key":"e_1_2_14_40_2","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti\u2010inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow DC","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7250.1642"},{"key":"e_1_2_14_42_2","first-page":"5767","article-title":"Selective inhibition of cyclooxygenase\u20102 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells","volume":"60","author":"Souza RF","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.6.422"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02195.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02195.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02195.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:07:28Z","timestamp":1697454448000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02195.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,16]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02195.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02195.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,16]]}}}